The power of drug samples
Drug samples provided to doctors by brand firms are "probably the biggest thwart on improving generic fill rate," Excellus Blue Cross Blue Shield Chief Pharmacy Officer Joel Owerbach said at an April 9 briefing on generic drug utilization sponsored by the BCBS Association. Samples, which brand firms say can help reduce costs for needy patients and serve as emergency supplies during catastrophes, are becoming an increasing focus of detailing now that the PhRMA marketing code has limited the other items, such as pens or lunches, that firms can provide physicians (1"The Pink Sheet," March 30, 2009, p. 13)
You may also be interested in...
Coupon redemptions for prescription drugs more than doubled in 2008 compared to 2007, according to a telephone and internet study of 8,700 consumers conducted by Manhattan Research, a research division of Decision Resources
Karyopharm and GSK should soon learn whether the European Medicines Agency will recommend EU approval for their respective products, selinexor and dostarlimab.
The fourth quarter proved to be challenging for Novartis, with its dermatology, ophthalmology and oncology products – and Zolgensma – feeling the impact of COVID-19 lockdowns. The company is hoping for much better things in the second part of 2021.